2
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other
1
Conditions
Hyperthermia
22
Sarcoma
8
Uterine Cervical Neoplasms
7
Breast Neoplasms
6
Rectal Neoplasms
5
Prostatic Neoplasms
5
Ovarian Neoplasms
5
Colonic Neoplasms
5
Neoplasms
4
Neoplasm Metastasis
4
Head and Neck Neoplasms
4
Urinary Bladder Neoplasms
3
Melanoma
3
Lung Neoplasms
3
Carcinoma, Hepatocellular
3
Sarcoma, Synovial
2
Neurofibrosarcoma
2
Liver Neoplasms
2
Liposarcoma
2
Leiomyosarcoma
2
Histiocytoma, Malignant Fibrous
2
Fibrosarcoma
2
Colorectal Neoplasms
2
Carcinoma, Ovarian Epithelial
2
Unspecified Adult Solid Tumor, Protocol Specific
1
Squamous Cell Carcinoma of Head and Neck
1
Solid Tumors
1
Small Cell Lung Carcinoma
1
Sarcoma, Clear Cell
1
Sarcoma, Alveolar Soft Part
1
Interventions
Metformin
7
Testosterone
2
Pioglitazone
2
Magnetic Resonance Spectroscopy
2
Inositol
2
Exercise
2
Ethinyl Estradiol
2
Blood Pressure
2
semaglutide
1
maltodextrin
1
drospirenone and ethinyl estradiol combination
1
drospirenone
1
bupropion hydrochloride, naltrexone hydrochoride drug combination
1
Walking
1
Vascular Stiffness
1
Ultrasonography
1
Triptorelin Pamoate
1
Topiramate
1
Tirzepatide
1
Sugars
1
Spironolactone
1
Qsymia
1
Pyruvic Acid
1
Pulse Wave Analysis
1
Preoperative Exercise
1
Phlebotomy
1
Phentermine
1
Pancreaticoduodenectomy
1
Orchiectomy
1
Observation
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Metabolic Syndrome
×
Diathermy
×
Clear all
NCT03644524
2018-08-23
CMH
University of Oregon
Phase NA
Completed
20 enrolled